Cargando…

Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas

Diffuse large B cell lymphoma (DLBCL) is a clinically and genetically heterogeneous disease. A small subset of DLBCLs has translocations involving the MYC locus and an additional group has a molecular signature resembling Burkitt lymphoma (mBL). Presently, identification of such cases by morphology...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kluk, Michael J., Chapuy, Bjoern, Sinha, Papiya, Roy, Alyssa, Cin, Paola Dal, Neuberg, Donna S., Monti, Stefano, Pinkus, Geraldine S., Shipp, Margaret A., Rodig, Scott J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325231/ https://www.ncbi.nlm.nih.gov/pubmed/22511926 http://dx.doi.org/10.1371/journal.pone.0033813

Ejemplares similares

CXCR4 upregulation is an indicator of sensitivity to B-cell receptor/PI3K blockade and a potential resistance mechanism in B-cell receptor-dependent diffuse large B-cell lymphomas
por: Chen, Linfeng, et al.
Publicado: (2020)

Diffuse large B-cell lymphomas have spatially defined, tumor immune microenvironments revealed by high-parameter imaging
por: Wright, Kyle T., et al.
Publicado: (2023)

IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E-myc Mice
por: Vecchio, Eleonora, et al.
Publicado: (2020)

Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis
por: Li, Amy, et al.
Publicado: (2019)

Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma
por: Pasqualucci, Laura, et al.
Publicado: (2006)

Sphingosine-1-Phosphate Receptor 1 in Classical Hodgkin Lymphoma: Assessment of Expression and Role in Cell Migration
por: Kluk, Michael J., et al.
Publicado: (2013)

The Molecular ‘Myc-anisms’ Behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics
por: McAnulty, Jessica, et al.
Publicado: (2020)

Genetic and immunohistochemical profiling of NK/T-cell lymphomas reveals prognostically relevant BCOR-MYC association
por: Oishi, Naoki, et al.
Publicado: (2022)

Patient-Specific Modeling of Diffuse Large B-Cell Lymphoma
por: Thobe, Kirsten, et al.
Publicado: (2021)

Targeting MYC-driven lymphoma: lessons learned and future directions
por: Martínez-Martín, Sandra, et al.
Publicado: (2023)

Diffuse large B-cell lymphoma: An immunohistochemical approach to diagnosis
por: Sethi, Aashka, et al.
Publicado: (2019)

Mnt modulates Myc-driven lymphomagenesis
por: Campbell, Kirsteen J, et al.
Publicado: (2017)

c-Myc oncogene expression in selected odontogenic cysts and tumors: An immunohistochemical study
por: Moosvi, Zama, et al.
Publicado: (2013)

The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomas
por: D'Andrea, Aleco, et al.
Publicado: (2016)

Targeting Translation Initiation by Synthetic Rocaglates for Treating MYC-driven Lymphomas
por: Zhang, Xuan, et al.
Publicado: (2019)

MYC-Driven Pathways in Breast Cancer Subtypes
por: Fallah, Yassi, et al.
Publicado: (2017)

Gene Transactivation and Transrepression in MYC-Driven Cancers
por: Scafuro, Marika, et al.
Publicado: (2021)

Copy Number Alteration and Mutational Profile of High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements, Diffuse Large B-Cell Lymphoma with MYC-Rearrangement, and Diffuse Large B-Cell Lymphoma with MYC-Cluster Amplification
por: Miyaoka, Masashi, et al.
Publicado: (2022)

A critical appraisal of the immunohistochemical detection of the c-myc oncogene product in colorectal cancer.
por: Jones, D. J., et al.
Publicado: (1987)

Tuberous sclerosis complex is required for tumor maintenance in MYC‐driven Burkitt's lymphoma
por: Hartleben, Götz, et al.
Publicado: (2018)

Genome-wide analysis of p53-regulated transcription in Myc-driven lymphomas
por: Tonelli, C, et al.
Publicado: (2017)

BCL-W makes only minor contributions to MYC-driven lymphoma development
por: Diepstraten, Sarah T., et al.
Publicado: (2023)

MYC is essential for the formation and maintenance of germinal centers
por: Calado, Dinis Pedro, et al.
Publicado: (2012)

Gfi1 upregulates c-Myc expression and promotes c-Myc-driven cell proliferation
por: Zhang, Yangyang, et al.
Publicado: (2020)

Immunohistochemical and Molecular Characteristics with Prognostic Significance in Diffuse Large B-Cell Lymphoma
por: Bellas, Carmen, et al.
Publicado: (2014)

Prognostic value of immunohistochemical algorithms in gastrointestinal diffuse large B-cell lymphoma
por: Hwang, Hee Sang, et al.
Publicado: (2013)

The spliceosome is a therapeutic vulnerability in MYC-driven cancer
por: Hsu, Tiffany Y-T., et al.
Publicado: (2015)

FoxO3 suppresses Myc-driven lymphomagenesis
por: Vandenberg, C J, et al.
Publicado: (2016)

Mouse medulloblastoma driven by CRISPR activation of cellular Myc
por: Vo, BaoHan T., et al.
Publicado: (2018)

Therapeutic Approaches Targeting MYC-Driven Prostate Cancer
por: Rebello, Richard J., et al.
Publicado: (2017)

The UVSSA complex alleviates MYC-driven transcription stress
por: Sato, Mai, et al.
Publicado: (2021)

Targeting protein folding in N‐Myc‐driven medulloblastoma
por: Valinciute, Gintvile, et al.
Publicado: (2023)

Spotlight on New Therapeutic Opportunities for MYC-Driven Cancers
por: D’Avola, Annalisa, et al.
Publicado: (2023)

Deletion of the transcriptional regulator TFAP4 accelerates c-MYC-driven lymphomagenesis
por: Potts, Margaret A., et al.
Publicado: (2023)

New MYC IHC Classifier Integrating Quantitative Architecture Parameters to Predict MYC Gene Translocation in Diffuse Large B-Cell Lymphoma
por: Bigras, Gilbert, et al.
Publicado: (2018)

MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B‐cell lymphoma patients
por: Wang, Yanjie, et al.
Publicado: (2023)

MYC’xing it up: zebrafish B ALL models provide insight into MYC-driven disease and relapse
por: Sá da Bandeira, Diana, et al.
Publicado: (2020)

A Regulatory Loop of FBXW7-MYC-PLK1 Controls Tumorigenesis of MYC-Driven Medulloblastoma
por: Wang, Dong, et al.
Publicado: (2021)

PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma
por: D’Avola, Annalisa, et al.
Publicado: (2022)

Oxidative stress enhances the therapeutic action of a respiratory inhibitor in MYC‐driven lymphoma
por: Donati, Giulio, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dish4b8ekrkc7d7qvun47f5ea8